Dah‐Cherng Yeh

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial

Nadia Harbeck, Chiun‐Sheng Huang, Sara A. Hurvitz et al. · The Lancet Oncology · 2016 · 151 citations

Medicine, Oncology, Pharmacology +17

Perioperative Parenteral Tranexamic Acid in Liver Tumor Resection

Cheng-Chung Wu, Wai‐Meng Ho, Shao‐Bin Cheng et al. · Annals of Surgery · 2006 · 141 citations · Full text

Medicine, Perioperative Medicine, Surgery +15

Prediction of breast cancer molecular subtypes on DCE-MRI using convolutional neural network with transfer learning between two centers

Yang Zhang, Jeon‐Hor Chen, Yezhi Lin et al. · European Radiology · 2020 · 137 citations · Full text

Computing, Oncology, Radiology +14

Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure

Cheng‐Chung Wu, William‐Lin Ho, Jung-Ta Chen et al. · Journal of the American College of Surgeons · 1999 · 87 citations · Full text

Medicine, Oncology, Surgery +13